Logo image of EYEN

EYENOVIA INC (EYEN) Stock Price, Quote, News and Overview

NASDAQ:EYEN - Nasdaq - US30234E2037 - Common Stock - Currency: USD

1.77  -0.26 (-12.81%)

After market: 1.7302 -0.04 (-2.25%)

EYEN Quote, Performance and Key Statistics

EYENOVIA INC

NASDAQ:EYEN (5/23/2025, 9:31:02 PM)

After market: 1.7302 -0.04 (-2.25%)

1.77

-0.26 (-12.81%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High124.8
52 Week Low0.85
Market Cap5.01M
Shares2.83M
Float2.74M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-11 2025-08-11/amc
IPO01-25 2018-01-25


EYEN short term performance overview.The bars show the price performance of EYEN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 50 -50

EYEN long term performance overview.The bars show the price performance of EYEN in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of EYEN is 1.77 USD. In the past month the price increased by 62.39%. In the past year, price decreased by -96.89%.

EYENOVIA INC / EYEN Daily stock chart

EYEN Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 51.87 676.59B
JNJ JOHNSON & JOHNSON 15.22 367.98B
NVO NOVO-NORDISK A/S-SPONS ADR 19.24 298.97B
NVS NOVARTIS AG-SPONSORED ADR 13.57 222.69B
AZN ASTRAZENECA PLC-SPONS ADR 18.93 218.30B
MRK MERCK & CO. INC. 9.96 195.22B
PFE PFIZER INC 7.26 132.26B
SNY SANOFI-ADR 13.57 127.25B
BMY BRISTOL-MYERS SQUIBB CO 6.38 95.34B
GSK GSK PLC-SPON ADR 7.02 78.23B
ZTS ZOETIS INC 27.01 72.38B
HLN HALEON PLC-ADR 22.73 50.23B

About EYEN

Company Profile

EYEN logo image Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company is headquartered in New York City, New York and currently employs 13 full-time employees. The company went IPO on 2018-01-25. The company is focused on the commercialization of Mydcombi (tropicamide+phenylephrine ophthalmic spray) for mydriasis, as well as clobetasol propionate ophthalmic suspension 0.05% to reduce pain and inflammation following ocular surgery. Its product line includes Mydcombi, clobetasol propionate, and therapeutic programs, MicroPine and MicroLine. Mydcombi is its fixed combination formulation of tropicamide-phenylephrine for inducing mydriasis for diagnostic procedures and in conditions where short-term pupil dilation is desired. MicroPine is its topical therapy for the treatment of progressive myopia, a disease associated with pathologic axial elongation of the eye and sclero-retinal stretching. MicroLine is its investigational pharmacologic treatment for presbyopia, a non-preventable, age-related hardening of the lens.

Company Info

EYENOVIA INC

295 Madison Ave Ste 2400

New York City NEW YORK 10017 US

CEO: Tsontcho Ianchulev

Employees: 14

EYEN Company Website

EYEN Investor Relations

Phone: 18137669539

EYENOVIA INC / EYEN FAQ

What is the stock price of EYENOVIA INC today?

The current stock price of EYEN is 1.77 USD. The price decreased by -12.81% in the last trading session.


What is the ticker symbol for EYENOVIA INC stock?

The exchange symbol of EYENOVIA INC is EYEN and it is listed on the Nasdaq exchange.


On which exchange is EYEN stock listed?

EYEN stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for EYENOVIA INC stock?

8 analysts have analysed EYEN and the average price target is 163.2 USD. This implies a price increase of 9120.34% is expected in the next year compared to the current price of 1.77. Check the EYENOVIA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is EYENOVIA INC worth?

EYENOVIA INC (EYEN) has a market capitalization of 5.01M USD. This makes EYEN a Nano Cap stock.


How many employees does EYENOVIA INC have?

EYENOVIA INC (EYEN) currently has 14 employees.


What are the support and resistance levels for EYENOVIA INC (EYEN) stock?

EYENOVIA INC (EYEN) has a support level at 1.11. Check the full technical report for a detailed analysis of EYEN support and resistance levels.


Is EYENOVIA INC (EYEN) expected to grow?

The Revenue of EYENOVIA INC (EYEN) is expected to grow by 400.98% in the next year. Check the estimates tab for more information on the EYEN EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy EYENOVIA INC (EYEN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does EYENOVIA INC (EYEN) stock pay dividends?

EYEN does not pay a dividend.


When does EYENOVIA INC (EYEN) report earnings?

EYENOVIA INC (EYEN) will report earnings on 2025-08-11, after the market close.


What is the Price/Earnings (PE) ratio of EYENOVIA INC (EYEN)?

EYENOVIA INC (EYEN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-50.93).


What is the Short Interest ratio of EYENOVIA INC (EYEN) stock?

The outstanding short interest for EYENOVIA INC (EYEN) is 2.92% of its float. Check the ownership tab for more information on the EYEN short interest.


EYEN Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to EYEN. When comparing the yearly performance of all stocks, EYEN is a bad performer in the overall market: 92.88% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

EYEN Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to EYEN. EYEN has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

EYEN Financial Highlights

Over the last trailing twelve months EYEN reported a non-GAAP Earnings per Share(EPS) of -50.93. The EPS increased by 4.98% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -1358.27%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%51.88%
Sales Q2Q%981.08%
EPS 1Y (TTM)4.98%
Revenue 1Y (TTM)2103.85%

EYEN Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 48% to EYEN. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of 33.51% and a revenue growth 400.98% for EYEN


Ownership
Inst Owners3.36%
Ins Owners0.8%
Short Float %2.92%
Short Ratio0.36
Analysts
Analysts47.5
Price Target163.2 (9120.34%)
EPS Next Y33.51%
Revenue Next Year400.98%